Miller Value Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-388,380	Closed	-$42M	–	95
2019 Q4	$42M	Sell	388,380 -60,400	-13%	-$6.46M	1.5%	34
2019 Q3	$44M	Hold	448,780	–	–	1.78%	29
2019 Q2	$58.8M	Buy	448,780 +1,100	+0.2%	+$142K	2.35%	23
2019 Q1	$60.5M	Sell	447,680 -455	-0.1%	-$56.6K	2.41%	21
2018 Q4	$43.6M	Sell	448,135 -690	-0.2%	-$81.6K	1.99%	25
2018 Q3	$62.4M	Buy	448,825 +6,480	+1%	+$813K	2.03%	23
2018 Q2	$54.9M	Buy	442,345 +21,280	+5%	+$2.49M	2.06%	26
2018 Q1	$46.9M	Sell	421,065 -15,800	-4%	-$1.89M	2.01%	22
2017 Q4	$52.2M	Sell	436,865 -7,560	-2%	-$921K	2.26%	23
2017 Q3	$62.3M	Sell	444,425 -6,300	-1%	-$856K	2.87%	19
2017 Q2	$54.8M	Buy	450,725 +92,025	+26%	+$10.7M	2.49%	21
2017 Q1	$43.5M	Buy	358,700 +258,990	+260%	+$33.4M	2.25%	23
2016 Q4	$12.2M	Buy	+99,710	New	+$12.2M	0.65%	35